These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients]. Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346 [TBL] [Abstract][Full Text] [Related]
4. Correlation between increased colloid osmotic pressure and the resolution of refractory ascites after transjugular intrahepatic portosystemic shunt. Schiano TD; Black M; Hills C; Ter H; Bellary S; Miller LS South Med J; 2000 Mar; 93(3):305-9. PubMed ID: 10728519 [TBL] [Abstract][Full Text] [Related]
5. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of refractory ascites using a transjugular intrahepatic portosystemic shunt (TIPS). Clinical case]. Zapata R; Fava M Rev Med Chil; 1999 Oct; 127(10):1229-35. PubMed ID: 10835740 [TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841 [TBL] [Abstract][Full Text] [Related]
8. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397 [TBL] [Abstract][Full Text] [Related]
9. Complicated hernia presentation in patients with advanced cirrhosis and refractory ascites: management and outcome. Telem DA; Schiano T; Divino CM Surgery; 2010 Sep; 148(3):538-43. PubMed ID: 20346479 [TBL] [Abstract][Full Text] [Related]
10. Surgical repair of umbilical hernias in cirrhosis with ascites. Triantos CK; Kehagias I; Nikolopoulou V; Burroughs AK Am J Med Sci; 2011 Mar; 341(3):222-6. PubMed ID: 20890175 [TBL] [Abstract][Full Text] [Related]
11. Risk of hernia incarceration following transjugular intrahepatic portosystemic shunt placement. Smith MT; Rase B; Woods A; Trotter J; Gipson M; Kondo K; Ray C; Durham J J Vasc Interv Radiol; 2014 Jan; 25(1):58-62. PubMed ID: 24269791 [TBL] [Abstract][Full Text] [Related]
12. Management of complicated umbilical hernias in patients with end-stage liver disease and refractory ascites. Fagan SP; Awad SS; Berger DH Surgery; 2004 Jun; 135(6):679-82. PubMed ID: 15179375 [No Abstract] [Full Text] [Related]
13. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites]. Ainsworth MA; Nielsen OH Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966 [No Abstract] [Full Text] [Related]
14. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219 [TBL] [Abstract][Full Text] [Related]
15. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed. Membreno F; Baez AL; Pandula R; Walser E; Lau DT J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494 [TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. Albillos A; Bañares R; González M; Catalina MV; Molinero LM J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922 [TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality. Russo MW; Sood A; Jacobson IM; Brown RS Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358 [TBL] [Abstract][Full Text] [Related]
18. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Colombato L J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487 [TBL] [Abstract][Full Text] [Related]